A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

NCT00975481 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Huntington's Disease

Interventions

DRUG: dimebon
DRUG: dimebon
DRUG: dimebon
DRUG: placebo
DRUG: alprazolam
DRUG: alprazolam

Sponsor

Pfizer

Collaborators

[object Object]